InvestorsHub Logo
Followers 20
Posts 137
Boards Moderated 0
Alias Born 02/17/2017

Re: None

Tuesday, 07/06/2021 11:25:42 AM

Tuesday, July 06, 2021 11:25:42 AM

Post# of 403092
International Pharmas doing clinical trials in Russia. Putin won't and nor does he want to prematurely obtain early trial results on B, or any other drug for that matter, being conducted in Russia. Why? Because clinical trials being conducted there will be a cash cow for Russia for decades to come once they are established a safe and bonafide player. Economically speaking Russia is in decline and has been faltering badly for years. Revenues from crude oil has been declining dramatically from years gone by. Global pharmaceutical companies are now using them for clinical trials of their pipeline drugs. Their safety record and efficiency has been verified as being better that our own system of clinical trials in the US and that is also is true of the EU system.
And what International Pharmas are testing in Russia:
1. Merck(USA) 4 studies 500 subjects
2. Novartis(Switz.) 4 studies 77 subjects
3. Interun Therapeutics (Ireland) 3 studies 466 subjects
4.Acadia Pharm. (USA) 3 studies 158 subjects
5.Minerva Pharm.(Greece) 2 studies 380 subjects
6.Rompharm (Romania) 2 studies subjects 330
7.Sentis Pharma (India) 2 studies subjects 264
8.Janssen(J&J) 2 studies subjects 160
9.AstraZenica(UK-Swedish) 2 studies subjects 128
10.Novo Nordisc(Denmark) 2 studies subjects 118
https://across.global/wp-content/uploads/2020/06/Synergy_Orange_Paper_Russia_2019Q1.pdf

Their costs of running trials are significantly cheaper than conducting them in the USA and the EU countries. Putin is ruthless, but he is a very smart man. He would not jeopardize the fledgling Clinical Trials industry that would become a major player on the world stage if he stepped in prematurely. He will wait with the rest of us for the proper protocols of releasing trial data. Additionally, the FDA and Europe's equivalent are on site in Russia overseeing the trials of American Pharmas. The FDA's oversight and the EU equivalent monitoring is what has given Russia the accolades and reason that worldwide Pharmas trust their Clinical Trial System. But that's just my opinion. IMO it was genius that Leo had the insight and foresight to utilize the Russian Clinical Trials system.
And to refute the argument that their vaccine (Sputnik) that Russia administered for its people is lacking efficacy or failed efficacy proves nothing. Their vaccine most likely went through a complete different trial scrutiny from the Clinical Trial system in place and Putin most likely had input on their vaccine. The drugs that US & EU Pharmas go through in Russia and the on site oversight that the FDA requires for verification of the proper protocols for phase 1,2,3 went through a much more vigorous protocols with international oversight at the venue sites where drugs were given for the different phase studies.
https://credevo.com/articles/2018/07/30/russia-clinical-trial-regulatory-process/

And it will be the success in Russia that will protect IPIX and B from being buried by Big Pharma and lobbyists here from reaching it’s true capabilities. BP can’t keep that enigmatic cat in the bag for much longer. IPIX will shine and prosper for all us longs and more importantly will save millions of lives from suffering and deaths to individuals and their families. For me financial remuneration will just be the icing on the cake. I welcome intelligent and thoughtful discourse.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News